Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives Publisher Pubmed



Abadi B1, 2, 3 ; Yazdanpanah N4, 5 ; Nokhodchi A6 ; Rezaei N4, 5, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Brain Cancer Research Core (BCRC), Universal Scientific Education and Research Network (USERN), Kerman, Iran
  3. 3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Kerman, Iran
  4. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  6. 6. Pharmaceutics Research Lab, School of Life Sciences, University of Sussex, Brighton, UK, United Kingdom
  7. 7. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Advanced Drug Delivery Reviews Published:2021


Abstract

Glioblastoma multiform (GBM) is considered as the most lethal tumor among CNS malignancies. Although immunotherapy has achieved remarkable advances in cancer treatment, it has not shown satisfactory results in GBM patients. Biomaterial science, along with nanobiotechnology, is able to optimize the efficiency of immunotherapy in these patients. They can be employed to provide the specific activation of immune cells in tumor tissue and combinational therapy as well as preventing systemic adverse effects resulting from hyperactivation of immune responses and off-targeting effect. Advance biomaterials in this field are classified into targeting nanocarriers and localized delivery systems. This review will offer an overview of immunotherapy strategies for glioblastoma and advance delivery systems for immunotherapeutics that may have a high potential in glioblastoma treatment. © 2021
Related Docs
View other Related Docs
1. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy, Cancers (2022)
2. The Role of Cell Membrane-Coated Nanoparticles As a Novel Treatment Approach in Glioblastoma, Frontiers in Molecular Biosciences (2023)
3. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
4. Nano-Immunotherapy: Overcoming Delivery Challenge of Immune Checkpoint Therapy, Journal of Nanobiotechnology (2023)
5. Immunoengineering in Glioblastoma Imaging and Therapy, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2019)
6. The Current Landscape of Car T-Cell Therapy for Solid Tumors: Mechanisms, Research Progress, Challenges, and Counterstrategies, Frontiers in Immunology (2023)
7. Tumor Immunology, Clinical Immunology (2022)
8. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (19)
Hamid Reza Mirzaei (3)
Other Related Docs
9. Smart Bio-Encapsulation for Immunotherapy, Smart Nanomaterials for Bioencapsulation (2022)
10. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy, Clinical and Translational Oncology (2023)
11. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities, Chemical Reviews (2019)
12. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment, Cellular and Molecular Neurobiology (2023)
13. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms, Vaccines (2022)
14. Restoring Endogenous Repair Mechanisms to Heal Chronic Wounds With a Multifunctional Wound Dressing, Molecular Pharmaceutics (2021)
15. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
16. Development of Neoantigens: From Identification in Cancer Cells to Application in Cancer Vaccines, Expert Review of Vaccines (2022)
17. The Therapeutic Effect of Mrna Vaccines in Glioma: A Comprehensive Review, Expert Review of Clinical Immunology (2025)
18. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
19. Neurological Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy, Expert Review of Clinical Immunology (2023)
20. Nanocarriers in Glioblastoma Treatment: A Neuroimmunological Perspective, Reviews in the Neurosciences (2024)
21. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
22. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
23. Immunotherapy in Aml: A Brief Review on Emerging Strategies, Clinical and Translational Oncology (2021)
24. A Review of Dna Nanoparticles-Encapsulated Drug/Gene/Protein for Advanced Controlled Drug Release: Current Status and Future Perspective Over Emerging Therapy Approaches, International Journal of Biological Macromolecules (2024)
25. Production of Car T-Cells by Gmp-Grade Lentiviral Vectors: Latest Advances and Future Prospects, Critical Reviews in Clinical Laboratory Sciences (2019)
26. Triple-Negative Breast Cancer Treatment Meets Nanoparticles: Current Status and Future Direction, Journal of Drug Delivery Science and Technology (2022)
27. Local Immunotherapy of Glioblastoma: A Comprehensive Review of the Concept, Journal of Neuroimmunology (2023)
28. Gene Therapy and Genetic Vaccines, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
29. Implications of Glioblastoma-Derived Exosomes in Modifying the Immune System: State-Of-The-Art and Challenges, Reviews in the Neurosciences (2025)
30. Biological Identity of Nanoparticles in Vivo: Clinical Implications of the Protein Corona, Trends in Biotechnology (2017)
31. Mesenchymal Stem Cell-Derived Antimicrobial Peptides As Potential Anti-Neoplastic Agents: New Insight Into Anticancer Mechanisms of Stem Cells and Exosomes, Frontiers in Cell and Developmental Biology (2022)
32. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
33. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
34. The Bio-Interface Between Functionalized Au Nr@Go Nanoplatforms With Protein Corona and Their Impact on Delivery and Release System, Colloids and Surfaces B: Biointerfaces (2019)
35. Recent Advances in Regenerative Medicine Strategies for Cancer Treatment, Biomedicine and Pharmacotherapy (2021)
36. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
37. Multiscale Technologies for Treatment of Ischemic Cardiomyopathy, Nature Nanotechnology (2017)
38. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
39. The Potential Use of Therapeutics and Prophylactic Mrna Vaccines in Human Papillomavirus (Hpv), Virology Journal (2024)
40. Nanovaccines for Cancer Immunotherapy: Focusing on Complex Formation Between Adjuvant and Antigen, International Immunopharmacology (2023)
41. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)
42. Dna Vaccines As Promising Immuno-Therapeutics Against Cancer: A New Insight, Frontiers in Immunology (2024)
43. Current and Future Perspectives of Pd-1/Pdl-1 Blockade in Cancer Immunotherapy, Journal of Immunology Research (2021)
44. The Molecular Mechanism of Actions and Clinical Utilities of Tumor Infiltrating Lymphocytes in Gastrointestinal Cancers: A Comprehensive Review and Future Prospects Toward Personalized Medicine, Frontiers in Immunology (2023)
45. Plant-Based Vaccines and Cancer Therapy: Where Are We Now and Where Are We Going?, Pharmacological Research (2021)
46. Chimeric Antigen Receptor T-Cell Therapy for Melanoma, Expert Review of Clinical Immunology (2021)
47. Recent Advances in Glioblastoma Multiforme Therapy: A Focus on Autophagy Regulation, Biomedicine and Pharmacotherapy (2022)
48. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)
49. Dendritic Cells Loaded With Exosomes Derived From Cancer Stem Cell-Enriched Spheroids As a Potential Immunotherapeutic Option, Journal of Cellular and Molecular Medicine (2021)
50. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)